Active Ingredient(s): Ropeginterferon alfa-2b-njft
FDA Approved: * November 12, 2021

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Besremi Overview

Ropeginterferon alfa-2b, sold under the brand name Besremi, is a medication used to treat polycythemia vera.[1][2][3][4] It is an interferon.[1][3] It is given by injection.[1][3] The most common side effects include low levels of white blood cells and platelets (blood components that help the blood to clot), muscle and joint pain, tiredness, flu-like symptoms and in...

Read more Besremi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Besremi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ropeginterferon alfa-2b-njft
  • Injection: 500 Mcg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ropeginterferon alfa-2b-njft or a similar ingredient: (1 result)